Evaluation of Nitric Oxide production by monocytes in children with acute lymphoblastic leukemia

Objective: Nitric Oxide (NO) is produced by different cells such as monocytes and plays an important role in non-specific immunity. In addition to its numerous physiological and pathophysiological effects, (NO) has tumoricidal activity. It seems patients with acute lymphoblastic leukemia (ALL) have...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: R Chegeni, A Zavaran Hosseini, AA Pour Fathollah, P Vosough
Formato: article
Lenguaje:EN
FA
Publicado: Babol University of Medical Sciences 2001
Materias:
R
Acceso en línea:https://doaj.org/article/eaab7c7f99e8407ca3329773230b2070
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eaab7c7f99e8407ca3329773230b2070
record_format dspace
spelling oai:doaj.org-article:eaab7c7f99e8407ca3329773230b20702021-11-10T09:20:53ZEvaluation of Nitric Oxide production by monocytes in children with acute lymphoblastic leukemia1561-41072251-7170https://doaj.org/article/eaab7c7f99e8407ca3329773230b20702001-01-01T00:00:00Zhttp://jbums.org/article-1-2879-en.htmlhttps://doaj.org/toc/1561-4107https://doaj.org/toc/2251-7170Objective: Nitric Oxide (NO) is produced by different cells such as monocytes and plays an important role in non-specific immunity. In addition to its numerous physiological and pathophysiological effects, (NO) has tumoricidal activity. It seems patients with acute lymphoblastic leukemia (ALL) have an imbalance and a defect in their immune system, especially in (NO) production. Therefore, in this study (NO) production by monocytes in children with (ALL) was evaluated before and after treatment and the results were compared to an age-matched reference population. Methods: Peripheral blood samples from 30 patients with (ALL) were collected before treatment and after induction of remission. Samples were also taken from 30 healthy children. Mononuclear cells and then monocytes were separated from blood samples and cultured in the presence of activators and inhibitors of (NO) pathway. For evaluation of (NO) production, nitrite level, which is a determinant of (NO) output, was measured in supernatants of culture media by the Griess method. Findings: The results show that the level of (NO) production before treatment in comparison to control group is significantly increased. Conclusion: Although there are cellular immunity defects in patients with (ALL), it seems (NO) production in a non-specific pathway by monocytes is not altered and may have anti-tumoral activity in these patients.R ChegeniA Zavaran HosseiniAA Pour FathollahP VosoughBabol University of Medical Sciencesarticlenitric oxidemonocytesacute lymphoblastic leukemiaMedicineRMedicine (General)R5-920ENFAMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 3, Iss 1, Pp 8-13 (2001)
institution DOAJ
collection DOAJ
language EN
FA
topic nitric oxide
monocytes
acute lymphoblastic leukemia
Medicine
R
Medicine (General)
R5-920
spellingShingle nitric oxide
monocytes
acute lymphoblastic leukemia
Medicine
R
Medicine (General)
R5-920
R Chegeni
A Zavaran Hosseini
AA Pour Fathollah
P Vosough
Evaluation of Nitric Oxide production by monocytes in children with acute lymphoblastic leukemia
description Objective: Nitric Oxide (NO) is produced by different cells such as monocytes and plays an important role in non-specific immunity. In addition to its numerous physiological and pathophysiological effects, (NO) has tumoricidal activity. It seems patients with acute lymphoblastic leukemia (ALL) have an imbalance and a defect in their immune system, especially in (NO) production. Therefore, in this study (NO) production by monocytes in children with (ALL) was evaluated before and after treatment and the results were compared to an age-matched reference population. Methods: Peripheral blood samples from 30 patients with (ALL) were collected before treatment and after induction of remission. Samples were also taken from 30 healthy children. Mononuclear cells and then monocytes were separated from blood samples and cultured in the presence of activators and inhibitors of (NO) pathway. For evaluation of (NO) production, nitrite level, which is a determinant of (NO) output, was measured in supernatants of culture media by the Griess method. Findings: The results show that the level of (NO) production before treatment in comparison to control group is significantly increased. Conclusion: Although there are cellular immunity defects in patients with (ALL), it seems (NO) production in a non-specific pathway by monocytes is not altered and may have anti-tumoral activity in these patients.
format article
author R Chegeni
A Zavaran Hosseini
AA Pour Fathollah
P Vosough
author_facet R Chegeni
A Zavaran Hosseini
AA Pour Fathollah
P Vosough
author_sort R Chegeni
title Evaluation of Nitric Oxide production by monocytes in children with acute lymphoblastic leukemia
title_short Evaluation of Nitric Oxide production by monocytes in children with acute lymphoblastic leukemia
title_full Evaluation of Nitric Oxide production by monocytes in children with acute lymphoblastic leukemia
title_fullStr Evaluation of Nitric Oxide production by monocytes in children with acute lymphoblastic leukemia
title_full_unstemmed Evaluation of Nitric Oxide production by monocytes in children with acute lymphoblastic leukemia
title_sort evaluation of nitric oxide production by monocytes in children with acute lymphoblastic leukemia
publisher Babol University of Medical Sciences
publishDate 2001
url https://doaj.org/article/eaab7c7f99e8407ca3329773230b2070
work_keys_str_mv AT rchegeni evaluationofnitricoxideproductionbymonocytesinchildrenwithacutelymphoblasticleukemia
AT azavaranhosseini evaluationofnitricoxideproductionbymonocytesinchildrenwithacutelymphoblasticleukemia
AT aapourfathollah evaluationofnitricoxideproductionbymonocytesinchildrenwithacutelymphoblasticleukemia
AT pvosough evaluationofnitricoxideproductionbymonocytesinchildrenwithacutelymphoblasticleukemia
_version_ 1718440152578129920